Citius Pharmaceuticals, Inc. Quarterly Weighted Average Number of Shares Outstanding, Basic from Q4 2010 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Citius Pharmaceuticals, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q4 2010 to Q3 2024.
  • Citius Pharmaceuticals, Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending September 30, 2024 was 6.73M shares, a 11.2% increase year-over-year.
  • Citius Pharmaceuticals, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2024 was 6.73M shares, a 11.2% increase from 2023.
  • Citius Pharmaceuticals, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 6.05M shares, a 95.9% decline from 2022.
  • Citius Pharmaceuticals, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 146M shares, a 34.5% increase from 2021.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 6.73M +675K +11.2% Jul 1, 2024 Sep 30, 2024 10-K 2024-12-27
Q2 2024 174M +20.1M +13.1% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-12
Q1 2024 159M +12.8M +8.77% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-14
Q4 2023 159M +12.7M +8.72% Oct 1, 2023 Dec 31, 2023 10-Q 2024-02-14
Q3 2023 6.05M -140M -95.9% Jul 1, 2023 Sep 30, 2023 10-K 2024-12-27
Q2 2023 154M +7.65M +5.23% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-12
Q1 2023 146M +210K +0.14% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-14
Q4 2022 146M +199K +0.14% Oct 1, 2022 Dec 31, 2022 10-Q 2024-02-14
Q3 2022 146M Jul 1, 2022 Sep 30, 2022 10-K 2023-12-29
Q2 2022 146M +8.98M +6.55% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 146M +50M +52.1% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-12
Q4 2021 146M Oct 1, 2021 Dec 31, 2021 10-Q 2023-02-10
Q2 2021 137M Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 96M Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q2 2014 18M 0 0% Apr 1, 2014 Jun 30, 2014 10-Q 2014-08-14
Q1 2014 18M 0 0% Jan 1, 2014 Mar 31, 2014 10-Q 2014-05-15
Q4 2013 18M 0 0% Oct 1, 2013 Dec 31, 2013 10-Q 2014-02-19
Q3 2013 18M 0 0% Jul 1, 2013 Sep 30, 2013 10-K 2014-02-06
Q2 2013 18M 0 0% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-14
Q1 2013 18M 0 0% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-15
Q4 2012 18M 0 0% Oct 1, 2012 Dec 31, 2012 10-Q 2014-02-19
Q3 2012 18M 0 0% Jul 1, 2012 Sep 30, 2012 10-K 2014-02-06
Q2 2012 18M 0 0% Apr 1, 2012 Jun 30, 2012 10-Q 2013-09-18
Q1 2012 18M 0 0% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-13
Q4 2011 18M 0 0% Oct 1, 2011 Dec 31, 2011 10-Q 2013-02-08
Q3 2011 18M Jul 1, 2011 Sep 30, 2011 10-K 2013-01-15
Q2 2011 18M Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-17
Q1 2011 18M Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-11
Q4 2010 18M Oct 1, 2010 Dec 31, 2010 10-Q 2012-02-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.